The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A phase 2 study of live-attenuated listeria monocytogenes cancer immunotherapy (ADXS11-001) in the treatment of persistent or recurrent cancer of the cervix (GOG-0265).
Warner King Huh
Consultant or Advisory Role - Advaxis/GOG (U)
William E. Brady
No relevant relationships to disclose
Kathleen N. Moore
No relevant relationships to disclose
Heather A. Lankes
No relevant relationships to disclose
Bradley J. Monk
No relevant relationships to disclose
Carol Aghajanian
No relevant relationships to disclose
Don S. Dizon
No relevant relationships to disclose
Deborah K Armstrong
No relevant relationships to disclose
Premal H. Thaker
No relevant relationships to disclose
Paula M. Fracasso
No relevant relationships to disclose